chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small red bumpy rash like patch on the inside of right wrist; Small red bumpy rash like patch on the inside of right wrist; This is a spontaneous report received from a contactable consumer, the patient. A 16-year-old non pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via unspecified route of administration in the left arm on 09Mar2021 at 10:45 (at the age of 16-year-old) as single dose for COVID-19 immunisation. Medical history included downs syndrome and hypothyroid. The patient did not have any allergies to medications, food, or other products. Concomitant medications included digestive enzymes (unspecified) and levothyroxine (MANUFACTURER UNKNOWN) received on unspecified date for unknown indication and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 17Mar2021, the patient developed a small, red, bumpy, rash-like patch, approximately two inches by one inch, on the inside of her right wrist, eight days after the shot. Therapeutic measures were taken as a result of adverse event with antibiotic ointment, covered the area . The clinical outcome of small red bumpy rash like patch was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a female patient of age between 22 to 25 years old with no pertinent medical history/drug allergies or drug reactions reported. On 27-APR-2015, reported as "2 weeks ago since the time of the report" the patient was vaccinated with the second dose GARDASIL (route, anatomical location, lot# and expiration date were not reported), for prevention of HPV. The patient reported since she receivee the 2nd dose of GARDASIL she experienced headaches. The patient received treatmentt with TYLENOL and MOTRIN. The pharmacist reported that the patient was not vaccinated at his pharmacy so he did not know the specific dates of vaccine administration or the specific product if was GARDASIL or GARDASIL 9. Patient sought medical attention: pharmacy visit. The outcome of headache was reported as not recovered/not resolved. Additional information has been requested.
Sent to ER for further evaluation following COVID vaccine on 9/19/21. Developed tingling in upper lip and tongue and felt lightheaded after receiving vaccine. ER found no signs of allergic reaction. Vitals were obtained prior to discharge the patient had blood pressure was 133/77 for heart rate of 80 and O2 saturation 100% on room air. Pt followed up next day via virtual visit with PCP (9/20/21). Subjectively reported hypotension in ER. Also reported yesterday pt felt dizzy, had itching in lips. Took claritin.
Patient called clinic this week to report itching of head, ears and chest 3 days after Zostavax administration. The itching lasted approximately 1 week and then disappeared completely. Pt. denies any other symptoms.
Approximately 16 hours post vax pt experienced crying, irritability, inconsolability; examination normal; WBC done normal.
Pain and swelling in my throat and severe tightness in my chest thirty minutes after the ijection. Severe ringing in my ears, could not sleep at night up to now. Went to ENT yesterday.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Pt fainted in waiting area shortly after vaccine administration. Quickly became responsive, talkative, and aware. Had patient lie down, elevated feet, gave pt water and potato chips to increase salt intake/ raise bp. Monitored patient for additional 30 minutes. Pt indicated he was feeling much better and left with family members with instructions to monitor him and have pt rest for remainder of the day. Tried to follow up with patient on 3/9, but phone number was out of service.
Per Dr., pt needed referrel to GI after receiving 2nd Anthrax vaccination.  The vaccination caused pancreaus damage.  Pt reported LLQ abdominal discomfort and diahrrhea that began a few weeks after each vaccine.  He states he currently has URI symptoms and continued loose BM's.  He continues to also have discomfort in the LLQ of the abdomen with certain movements.
24 hours after injection, I noticed raised, red itchy bumps (look like chigger bites) on my waist and around my lower legs. 36 hour after injection, I noticed a flat, red, more hive like area on my waist that was itchy 48 hours later I noticed more red raised itchy bumps around my waist
The morning after vaccine was given patient had red puffy cheeks, watery eyes, and a funny sounding voice.  There was no medication given, and patient is fine now.
pt recvd vax;arthralgias,mylagia,stiff neck,low grade fever 102;localized discomfort;diaphoretic in eve of 9jun;on 10jun,in for exam but now feeling better;originally presented w/ paronychial infect;f/u,3rd dose w/ similar rxn but milder;
left calf pain , swelling and redness, patient reports stating one week prior to being seen in the clinic on 19April2021, Patient was diagnosed with acute Embolism and Thrombosis of left popliteal Vein and started on Eliquis
Pt had MMR and varicella on 1/12/04 3 hrs later mom noted rash on the legs w/c spread throughout body. On exam pt had hives-possibly from vaccines.
Patient turned 18 years old on 3/4/2021. On 1/10/2021 and 2/6/2021, patient received dose #1 and dose #2 of Moderna COVID vaccine respectively. Patient should've received Pfizer COVID vaccine as a 17-year-old before turning 18. Per guidelines, if a 17-year-old received Moderna dose #1, Moderna should be administered as dose #2 to finish the series as off-label. There was no adverse event to the patient. This event is reported as an administration error.
Within minutes after receiving shot I became completely dizzy, lightheaded and started to faint. EMT came to my aid and took vitals all looked OK. I stayed in place until I felt better about 30 minutes. For the rest of that day and the next day I was extremely tired, a little nauseous, and kind of out of it. The third day I had very sore left arm at site and very sore and tender lymph notes on left side of Arm and trunk. Six days after the shot I came suddenly down with a massive headache and diarrhea. Al has since resolved and I am on day eight.
The 2 times i did i was violently ill; Initial information received on 03-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced the 2 times i did i was violently ill while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event "the 2 times i did i was violently ill" (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (The 2 times i did i was violently ill).  At time of reporting, the outcome was Unknown for the event the 2 times i did i was violently ill.
Developed sharp left lower quadrant pain sudden onset constant presented to Emergency Room after rest and over the counter medication did not help about four hours later.
Fever of 102, chills, red and warm ring around injection sight. She called her dr office and they told her to put ice on it and take Motrin. The ring kept getting bigger until it became a big knot. She went to the dr and gave her some antibiotics
Information has been received from a medical assistant(also reported as office manager) referring to a12 month old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy were not provided. On 03-MAY-2017, the patient was vaccinated with the second improperly stored dose of VAQTA (lot # M039202, expiration date: 11-MAR-2018; dose and route of administration were not provided) for prophylaxis (Incorrect product storage). No adverse effects were reported. The vaccine was involved in Vaccines For Children Program (VFC) stock and the VFC status appointment was reported as 1. The patient received the vaccine with the temperature excursion of 17.6 degrees Celsius for 74 hours and 8 minutes (also reported as 1 hour and 38 minutes). The vaccine was previously exposed to a temperature excursion in 13 degrees Celsius for 72 hours 30 minutes. Data logger was involved. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information is not expected as all correspondence was received. Sender's Comments: US-009507513-1704USA014784:
Patient presented with lesions indicating shingles infection on left abdomen 72 hours after injection. Patient seen in clinic by Dr. 05/23/2018 confirming presence of shingles still on abdomen.
Patient complained of feeling nausea and lightheaded around 3:54 pm. The patient was assisted to patient room and sat in chair. Patient began to sweat and skin was pale. The patient verbalized he felt like he was "going down". EMS called. Vital signs at 3:56 pm were blood pressure 82/50, pulse 58, oxygen saturation 95%. 0.3 mg of epi administered intramuscularly to right arm at 3:58 pm. Patient verbalized improvement in symptoms around 4:03 pm. Oxygen dropped to about 88% and back up to 96% and heart rate 88. EMS arrived around 4:10 pm and took blood pressure of 133/86. Patient transported to ER for further evaluation. Patient alert and oriented x4 at time of transfer.
1 wk p/recvd vx pt woke in middle of noc w/jerking movements of head & feet; crying, eye movements up & down; t101; episode lasted approx 5 mins; 11MAY92 telephone call to mom states pt was dx & treated for pin worms on 4MAY92;
multiple symptoms: shaking chills, headache, tinnitus, weakness, fatigue, somnolence, nausea. Onset at 9:30 AM May 8, 2021. No treatment other than bed rest and fluids incl. oral electrolytes. Symptoms fully resolved by 4:00 PM of the same day with the exception of the tinnitus, which had already diminished significantly.
allergic reaction; entire forearm turn red; allergic reaction; entire forearm turn red; This is a spontaneous report from a contactable consumer(patient). The 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL2346), Intramuscular (shot in the arm) on 07Jan2021 at single dose for covid-19 immunisation.  The patient medical history included AFib(Atrial fibrillation) and Blood pressure (abnormal), problem with Afib that's pretty under control, blood pressure that's also under control (further not clarified).  Concomitant medication included apixaban (ELIQUIS) and couple of different blood pressure medications.  The patient experienced allergic reaction; entire forearm turned red on 07Jan2021 about 2 hours afterwards vaccination, hydrocortisone as treatment for it, topical rubbed, for about an 1 hour up to. Patient stated that he was not experiencing it and it was the short term thing he had allergic reaction.  Outcome of events was recovered in Jan2021.
Approx. four days to a week later, shortness of breath while leaning back on floor. Never happened before without exertion of any kind. Recall some pounding in chest.  - NOTE: Shortness of breath resolved. Lasted for a few days.  Chest tightness, pressure in chest, uncomfortable feelings persisted pretty consistently ever since almost every day to some degree, often in the morning in bed. Note: Continues.  Recent to the time of reporting this,  i) November 28th, unusual sensations in different areas around the top of the skull, sometimes as a minor headache, sometimes sensation with no pain. Note: New occurrence, becoming fairly common, at least one or twice daily. ii) Finally so tingling sensations in the lower extremities, very minor sensations close to the skin, around joints, blood vessels; very minor but I know my body and not something I've experienced before the shot. Usually subsides with movement.
pt recvd vax; hard knot at inject site; tender; fever of 102.7;
Left arm muscle weakness just a couple of hours after vaccination.  Still experiencing today on 5/3 Un-normal menstural period - Just got done with mine 1 1/2 weeks ago, and just started today again.
Information has been received from a pharmacist concerning a female (age unknown) who, on an unspecified date, was vaccinated with a first dose of GARDASIL.  Subsequently, the patient was diagnosed with Hodgkin's lymphoma.  The patient was seen at the office.  At the time of the report, the patient was in remission.  No product quality complaint was involved.  Upon internal review Hodgkin's lymphoma was considered to be an other important medical event.  This is an amended report.  The serious criteria of other important medical event was changed to yes for Hodgkin's lymphoma.  Additional information has been requested.  06/09/2008 MR received from oncologist which include PCP records as well as outside consultant records. Pt seen by pediatriction 2/27/07 with lymphadenopathy at the base of the neck. Initially thought to be r/t recent dx of mono in November 2006. RTO 4/10/07 with same, as well as chills and fatigue. Refered to oncologist and seen 5/2/2007. Dxd with Hodgkin's Disease following excisional lymph node bx. Staged at level IIA. Port placed for chemo-6 cycles of ABVD, which was successful in achieving remission. No evidence of recurrence at f/u visits.
sore throat; This spontaneous case was reported by an other health care professional and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa drugs) and Penicillin allergy.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that the patient was taking Botox and Fillers in the past for which dates are unknown (Medications unknown).  No treatment information was provided.   This case was linked to MOD-2021-268536 (Patient Link).
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a female patient who received BOOSTRIX. On an unknown date, the patient received BOOSTRIX at an unknown dose. On an unknown date, an unknown time after receiving BOOSTRIX, the patient experienced rash and skin warm. On an unknown date, the outcome of the rash and skin warm were unknown. It was unknown if the reported the rash and skin warm to be related to BOOSTRIX.  Additional details were provided as follows: The age at vaccination was not reported. The patient had experienced a delayed reaction after receiving BOOSTRIX. She had a rash and the skin was hot to touch in the area also.
This solicited report as received from a non-healthcare professional refers to a 11 year old female patient who was enrolled in a Market Research. Patient's concurrent conditions, and medical history were not provided. Concomitant therapies included multiple unspecified vaccines administered on the same date. In approximately May 2016, the subject was vaccinated with first dose of GARDASIL (dose, route, lot # and expiration date were not provided). In May 2016, the patient experienced soreness at injection site (injection site pain). The patient recovered of the injection site pain 3 days after vaccination (approximately May 2016). The investigator considered the injection site pain to be related to GARDASIL. Additional information has been requested.
rash, half an inch in diameter, at the injection site; pain at the injection site; pink mark" at the injection site; This case was received via an unknown source no reference has been entered for a health authority on 30-Mar-2021 and was forwarded to Moderna on 30-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION, VACCINATION SITE RASH, and VACCINATION SITE PAIN in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION and VACCINATION SITE PAIN. On 30-Mar-2021, the patient experienced VACCINATION SITE RASH. On 28-Mar-2021, VACCINATION SITE DISCOLOURATION and VACCINATION SITE PAIN had resolved. At the time of the report, VACCINATION SITE RASH had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not reported. Treatment information as not reported.   Reporter did not allow further contact
She received the H1N1 flu nasal mist.  She began coughing and looking ill the next day; continued for several days, then got much worse after 5-6 days. Fever rose to about 100, coughing persisted.  She is better now (after 7 days) but still has a persistent, frequent cough.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions and allergies were not reported. The patient's concomitant medication included sterile diluent (MRK INJ) was properly stored. On 17-APR-2018, the patient was vaccinated with improperly stored VARIVAX (dose, units and frequency not reported) (lot # N027619 and expiration date: 04-OCT-2019) subcutaneously at a temperature from -9 degree Celsius (C) to 8 C for 2 hours. There was no previous temperature excursion to the vaccine. Digital data logger was involved. No product quality complaint was involved.
I developed a 3 inch by 1 inch itchy rash on the inside of my elbow, on my right arm, where i received the second injection.  The itch lasted for roughly 5 days and the area is still slightly discolored.  It has not increased to a level that I believe needs to be treated by a doctor.
Patient received vaccine about 9:30 am on 9/18/2014. By afternoon she developed chills, headache, 102 degrees temp and a general run-down feeling. Temperature resolved after taking 1000 mg TYLENOL about 730 pm.
Got sick of COVID-19 (omicron variant) after he had 3 doses of the Pfizer COVID-19 Vaccine; Got sick of COVID-19 (omicron variant) after he had 3 doses of the Pfizer COVID-19 Vaccine; Chronic fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 68-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", SUSPECTED COVID-19 (medically significant), outcome "recovered" and all described as "Got sick of COVID-19 (omicron variant) after he had 3 doses of the Pfizer COVID-19 Vaccine"; FATIGUE (non-serious), outcome "unknown", described as "Chronic fatigue".  Clinical Course: Reporter was a consumer. She explained that she has 3 doses of Pfizer-BioNTech COVID-19 Vaccine so far. Her physician recommended her to get the second booster dose (or fourth dose) of the vaccine, since she was a diabetic patient. Reporter said she knew that Pfizer might be working on a new formulation for the booster doses, which would be more effective against the omicron variant. Reporter wanted to know if she should get the second booster now or wait until the new formulation or she can receive the second booster dose now and then a possible third booster dose (fifth dose) when this new formulation was available. Reporter stated that she knows the immunity wanes after several months and she was thinking to get another dose of the vaccine by Fall instead of this time. He did not need to be hospitalized, he had chronic fatigue but overcame the infection with home cares.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
High fever 12 hours after receiving injection. Last 24 hours pt crying uncontrollable. Developed hives and loss of appetite.
The patient experienced syncope associated with Gardasil 9 administration; This spontaneous report has been received from a physician assistant via company representative referring to a 13-year-old female patient. The information regarding the patient's concurrent conditions, concomitant therapies, historical drugs, drug reactions or allergies, or pertinent medical history was unknown by the reporter.  On an unspecified date, the patient was vaccinated with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection as prophylaxis (strength, dosage schedule, route of administration, anatomical site of vaccination, vaccination scheme frequency, lot number, and expiration date were not reported).   On an unknown date (conflicting information: also reported as 19-OCT-2018), the patient experienced syncope associated to the administration of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). The patient sought medical attentions and was treated for the event with a cold rag placed on her forehead and was instructed to lie down due to the symptoms experienced.   The outcome of the event was unknown at the reporting time. It was unknown by the reporter if any laboratory diagnostic or studies were performed.  The causal relationship between HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) and the event occurrence was related.
Patient was given KINRIX at 2yr7m instead of two seperate vaccines as his age would dictate.
Hot and cold flashes, left arm red and swollen 4 x 6 inches. Shoulder joint extremely sore. Difficulty lifting arm. Body aches.
On  the morning of 3/3/2021 i felt a slight amount of discomfort in right armpit. The following night, 3/4/2021, muscle pain in upper back started to develop. The morning of 3/5/2021 the muscle pain had spread from upper back to neck and shoulders. The pain was severe enough to impede the ability to get dressed or drive.  I took Ibuprofen and noticed little relief, then took 1g of acetaminophen and experienced some relief. Pain persisted at same degree until the evening of  3/7/2021  where pain had started to noticeably subside. On morning of 3/8/2021,  armpit discomfort had ceased and muscle pain and been reduced to that of very slight soreness.  as on 3/10/2021 all pain had disappeared.